SG Americas Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $271M | Buy |
11,271,181
+1,757,886
| +18% | +$46M | 0.15% | 96 |
|
|
2026
Q1 | $267M | Buy |
9,513,295
+4,100,329
| +76% | +$109M | 0.29% | 46 |
|
|
2025
Q4 | $135M | Buy |
5,412,966
+3,821,709
| +240% | +$96.4M | 0.17% | 88 |
|
|
2025
Q3 | $40.5M | Buy |
1,591,257
+830,970
| +109% | +$20.5M | 0.14% | 91 |
|
|
2025
Q2 | $18.4M | Sell |
760,287
-60,399
| -7% | -$1.41M | 0.08% | 186 |
|
|
2025
Q1 | $20.8M | Buy |
820,686
+751,352
| +1,084% | +$19.7M | 0.07% | 195 |
|
|
2024
Q4 | $1.84M | Sell |
69,334
-682,869
| -91% | -$18.5M | 0.01% | 623 |
|
|
2024
Q3 | $21.8M | Sell |
752,203
-43,562
| -5% | -$1.27M | 0.08% | 144 |
|
|
2024
Q2 | $22.3M | Sell |
795,765
-1,516,094
| -66% | -$41.7M | 0.13% | 155 |
|
|
2024
Q1 | $64.2M | Buy |
2,311,859
+1,974,837
| +586% | +$54.8M | 0.31% | 59 |
|
|
2023
Q4 | $9.7M | Buy |
337,022
+248,583
| +281% | +$7.51M | 0.09% | 215 |
|
|
2023
Q3 | $2.93M | Sell |
88,439
-234,458
| -73% | -$8.29M | 0.03% | 522 |
|
|
2023
Q2 | $11.8M | Sell |
322,897
-1,389,288
| -81% | -$54.1M | 0.09% | 144 |
|
|
2023
Q1 | $69.9M | Buy |
1,712,185
+1,619,707
| +1,751% | +$70M | 0.81% | 18 |
|
|
2022
Q4 | $4.74M | Sell |
92,478
-990,549
| -91% | -$47.5M | 0.06% | 278 |
|
|
2022
Q3 | $47.4M | Buy |
1,083,027
+141,990
| +15% | +$6.9M | 0.59% | 29 |
|
|
2022
Q2 | $49.3M | Buy |
941,037
+684,182
| +266% | +$34.9M | 0.53% | 24 |
|
|
2022
Q1 | $13.3M | Sell |
256,855
-49,549
| -16% | -$2.57M | 0.1% | 165 |
|
|
2021
Q4 | $18.1M | Buy |
306,404
+154,410
| +102% | +$7.65M | 0.1% | 154 |
|
|
2021
Q3 | $6.54M | Sell |
151,994
-395,749
| -72% | -$17.5M | 0.03% | 425 |
|
|
2021
Q2 | $21.4M | Buy |
547,743
+266,223
| +95% | +$10.4M | 0.1% | 168 |
|
|
2021
Q1 | $10.2M | Sell |
281,520
-917,786
| -77% | -$32.6M | 0.05% | 286 |
|
|
2020
Q4 | $44.1M | Buy |
1,199,306
+1,101,253
| +1,123% | +$40.4M | 0.24% | 68 |
|
|
2020
Q3 | $3.41M | Sell |
98,053
-789,569
| -89% | -$27.7M | 0.02% | 492 |
|
|
2020
Q2 | $27.5M | Sell |
887,622
-129,228
| -13% | -$4.39M | 0.23% | 71 |
|
|
2020
Q1 | $31.5M | Buy |
1,016,850
+941,476
| +1,249% | +$32.1M | 0.3% | 53 |
|
|
2019
Q4 | $2.8M | Sell |
75,374
-858,755
| -92% | -$30.6M | 0.03% | 638 |
|
|
2019
Q3 | $31.8M | Sell |
934,129
-42,302
| -4% | -$1.54M | 0.26% | 61 |
|
|
2019
Q2 | $40.1M | Buy |
976,431
+851,906
| +684% | +$33.8M | 0.28% | 63 |
|
|
2019
Q1 | $5.02M | Sell |
124,525
-382,821
| -75% | -$15.3M | 0.05% | 415 |
|
|
2018
Q4 | $21M | Sell |
507,346
-397,419
| -44% | -$16.5M | 0.18% | 111 |
|
|
2018
Q3 | $37.8M | Buy |
904,765
+705,899
| +355% | +$27.2M | 0.28% | 59 |
|
|
2018
Q2 | $6.84M | Sell |
198,866
-310,472
| -61% | -$10.6M | 0.06% | 318 |
|
|
2018
Q1 | $17.1M | Sell |
509,338
-740,834
| -59% | -$25.5M | 0.14% | 122 |
|
|
2017
Q4 | $43M | Buy |
1,250,172
+1,211,306
| +3,117% | +$41.3M | 0.4% | 30 |
|
|
2017
Q3 | $1.32M | Sell |
38,866
-508,435
| -93% | -$16.3M | 0.01% | 1065 |
|
|
2017
Q2 | $17.4M | Sell |
547,301
-481,750
| -47% | -$15.2M | 0.16% | 131 |
|
|
2017
Q1 | $33.4M | Sell |
1,029,051
-1,630,785
| -61% | -$51.4M | 0.3% | 74 |
|
|
2016
Q4 | $82M | Buy |
2,659,836
+2,514,729
| +1,733% | +$76.8M | 0.69% | 23 |
|
|
2016
Q3 | $4.66M | Sell |
145,107
-199,730
| -58% | -$6.68M | 0.05% | 368 |
|
|
2016
Q2 | $11.5M | Sell |
344,837
-1,082,401
| -76% | -$34.5M | 0.08% | 183 |
|
|
2016
Q1 | $40.1M | Buy |
1,427,238
+929,889
| +187% | +$26.6M | 0.29% | 47 |
|
|
2015
Q4 | $15.2M | Sell |
497,349
-4,581,414
| -90% | -$144M | 0.11% | 158 |
|
|
2015
Q3 | $36.9M | Buy |
5,078,763
+4,428,952
| +682% | +$142M | 0.22% | 83 |
|
|
2015
Q2 | $20.7M | Sell |
649,811
-1,151,045
| -64% | -$37.5M | 0.14% | 107 |
|
|
2015
Q1 | $59.4M | Sell |
1,800,856
-3,368,582
| -65% | -$107M | 0.35% | 51 |
|
|
2014
Q4 | $153M | Buy |
5,169,438
+1,410,952
| +38% | +$40.5M | 0.75% | 23 |
|
|
2014
Q3 | $105M | Buy |
3,758,486
+587,698
| +19% | +$16.5M | 0.62% | 28 |
|
|
2014
Q2 | $89.3M | Buy |
3,170,788
+367,058
| +13% | +$10.5M | 0.52% | 32 |
|
|
2014
Q1 | $85.4M | Sell |
2,803,730
-2,337,341
| -45% | -$69.7M | 0.37% | 52 |
|
|
2013
Q4 | $149M | Sell |
5,141,071
-7,823,799
| -60% | -$228M | 0.62% | 26 |
|
|
2013
Q3 | $353M | Buy |
12,964,870
+5,347,572
| +70% | +$146M | 1.45% | 8 |
|
|
2013
Q2 | $202M | Buy |
+7,617,298
| New | +$210M | 0.99% | 14 |
|
Other funds holding PFE
SG Americas Securities's PFE Position: Q2 2026 in Review
SG Americas Securities increased its Pfizer (PFE) stake by 18% in Q2 2026, buying an estimated $46M and bringing the position to 11,271,181 shares worth $271M. The position accounts for 0.15% of the portfolio, ranked #96.
SG Americas Securities first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $353M in Q3 2013. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- SG Americas Securities held 11,271,181 shares of Pfizer worth $271M as of Q2 2026.
- SG Americas Securities bought 1,757,886 Pfizer shares in Q2 2026, an estimated $46M.
- Pfizer made up 0.15% of SG Americas Securities's portfolio in Q2 2026, its #96 holding.
- SG Americas Securities first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- SG Americas Securities's Pfizer position peaked at $353M in Q3 2013.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.